Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Aug 27, 2025; 17(8): 109678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109678
Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview
Jing-Qiu Zhang, De-Lei Cheng, Chun-Ze Zhou, Xin-Jian Xu
Jing-Qiu Zhang, Graduate School, Bengbu Medical University, Bengbu 233030, Anhui Province, China
De-Lei Cheng, Chun-Ze Zhou, Department of Interventional Radiology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230000, Anhui Province, China
Xin-Jian Xu, Department of Interventional Radiology, Jiangyin Hospital Affiliated to Nantong University, Jiangyin 214400, Jiangsu Province, China
Co-corresponding authors: De-Lei Cheng and Xin-Jian Xu.
Author contributions: Zhang JQ and Zhou CZ designed the overall concept and outline of the manuscript and wrote the paper; Cheng DL and Xu XJ made crucial and indispensable contributions toward the completion of the paper and thus qualified as the co-corresponding authors of the paper; Zhang JQ, Cheng DL, Zhou CZ, and Xu XJ contributed critical revision of the manuscript for important intellectual content; all authors have read and approved the final manuscript.
Supported by Hefei Natural Science Foundation, No. 202341.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: De-Lei Cheng, MD, Chief, Department of Interventional Radiology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei 230000, Anhui Province, China. chengdelei@hotmail.com
Received: May 20, 2025
Revised: June 11, 2025
Accepted: July 14, 2025
Published online: August 27, 2025
Processing time: 100 Days and 4.9 Hours
Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is widely used to treat portal hypertension and its complications patients with cirrhosis. However, managing post-TIPS hepatic encephalopathy (HE) remains a major clinical challenge. HE is characterized by a high incidence and a complex pathogenesis, influenced by various factors. Therefore, careful patient assessment and selection for TIPS is essential. While previous studies have identified several factors contributing to the occurrence of post-TIPS HE, there is a gap in the comprehensive integration of surgical procedural parameters and metabolic mechanisms within a multidimensional analysis. This minireview aims to optimize treatment protocols and refine management strategies by conducting a comprehensive analysis of risk factors, ultimately aiming to reduce the incidence of post-TIPS HE.

Keywords: Portosystemic shunt; Transjugular intrahepatic; Hepatic encephalopathy; Cirrhosis; Portal hypertension

Core Tip: The pathogenesis of hepatic encephalopathy (HE) following transjugular intrahepatic portosystemic shunt (TIPS) is complex, involving numerous risk factors. It is essential to recognize that HE is a multifactorial syndrome that necessitates a thorough understanding of various contributing factors. A comprehensive approach that includes preoperative individualized risk assessment, intraoperative management of portosystemic shunting, and postoperative prognostic care can provide evidence-based strategies for optimizing patient selection for TIPS. This approach aims to reduce the risk of HE following TIPS, improving long-term prognosis.